Abstract
The present disclosure relates to a novel crystalline form of 4-[3 chloro-4-(N’-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide paratoluene sulfonate which is represented by the following structural formula-1b, which is referred to as Lenvatinib paratoluene sulfonate.
Formula-1b
The present disclosure also relates to a process for the preparation of novel crystalline form of 4-[3 chloro-4-(N’-cyclopropylureido)phenoxy]-7-methoxy quinoline-6-carboxamide paratoluenesulfonate of formula-1b.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Kammari Balraju, Kamutam Sathish, MSN Laboratories Private Limited, R&D Center., "Novel crystalline form of 4-[3¬ chloro-4-(N’-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide paratoluenesulfonate and its process for the preparation", Technical Disclosure Commons, (October 28, 2025)
https://www.tdcommons.org/dpubs_series/8802